← Eichor
Study identifier: NCT06588244 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

INOCA-NA a Local Prospective Registry

Condition: Ischemia, Myocardial · Non-Obstructive Coronary Atherosclerosis · Microcirculatory Status  ·  Sponsor: Federico II University

PhaseN/A
Planned participants250
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The present study has the following objectives: 1. To investigate the prevalence of INOCA in patients referring for a clinically indicated coronary angiography (CA) c/o Division of Cardiology - Federico II University Hospital; 2. To stratify in INOCA endotypes patients according to the presence or absence of alternative (i.e. non obstructive CAD) causes of myocardial ischemia detected during CA clinically indicated through physiology tests; 3. to implement a stratified therapy in these patients considering the different INOCA endotypes and evaluate the impact on angina class and quality of life as well as cardiac hospitalization and coronary revascularization during 5 year follow up

This description comes directly from the study's public registry record.

Talk to the study team

Luigi Di Serafino, MD, PhD  ·  0039 347917374  ·  luigi.diserafino@unina.it

Always discuss trial participation with your own doctor first.

Locations (1)

DPT of Advanced Biomedical SciencesNaples, Italy, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06588244